(Q53138527)

11 May 2018

title

Feasibility of shortening 14-day hybrid therapy while maintaining an excellent Helicobacter pylori eradication rate. (English)

1 reference

11 May 2018

0 references

4

David Y Graham

1 reference

11 May 2018

Jeng-Yih Wu

1

1 reference

11 May 2018

Ping-I Hsu

series ordinal

2

1 reference

11 May 2018

Deng-Chyang Wu

series ordinal

3

1 reference

11 May 2018

Wen-Ming Wang

series ordinal

5

1 reference

11 May 2018

publication date

11 March 2014

1 reference

11 May 2018

published in

Helicobacter

1 reference

11 May 2018

volume

19

1 reference

11 May 2018

issue

3

1 reference

11 May 2018

page(s)

207-213

1 reference

11 May 2018

Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption

cites work

1 reference

Helicobacter pylori treatment in the era of increasing antibiotic resistance

21 January 2018

1 reference

Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.

21 January 2018

1 reference

Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children

21 January 2018

1 reference

Optimal therapy for Helicobacter pylori infections

21 January 2018

1 reference

Ten-day sequential treatment for Helicobacter pylori eradication in clinical practice.

21 January 2018

1 reference

14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial

21 January 2018

1 reference

Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence

21 January 2018

1 reference

Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days

21 January 2018

1 reference

Helicobacter pylori eradication therapy research: Ethical issues and description of results

21 January 2018

1 reference

Strategy for intention to treat analysis in randomised trials with missing outcome data

21 January 2018

1 reference

High-level beta-lactam resistance associated with acquired multidrug resistance in Helicobacter pylori

21 January 2018

1 reference

Analysis of rdxA and involvement of additional genes encoding NAD(P)H flavin oxidoreductase (FrxA) and ferredoxin-like protein (FdxB) in metronidazole resistance of Helicobacter pylori.

21 January 2018

1 reference

Antimicrobial susceptibility testing for Helicobacter pylori: sensitivity test results and their clinical relevance

21 January 2018

1 reference

Optimized nonbismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with high rates of antibiotic resistance

21 January 2018

1 reference

Evidence-based recommendations for successful Helicobacter pylori treatment

21 January 2018

1 reference

Clinical evaluation of a ten-day regimen with esomeprazole, metronidazole, amoxicillin, and clarithromycin for the eradication of Helicobacter pylori in a high clarithromycin resistance area

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/HEL.12113

1 reference

11 May 2018

1 reference

11 May 2018